(Q44449601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

title

US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

Corrigendum: Incorrect Spelling of Author's Name: US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses.

1 April 2020

corrigendum / erratum

1 reference

10.4111/ICU.2018.59.4.283

Crossref

DOI

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.4111/ICU.2018.59.4.283

author

Sri Ram Pentakota

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Hossein Sadeghi-Nejad

14

object named as

Hossein Sadeghi-Nejad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

Glen Gejerman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Patrick Ciccone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Martin Goldstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Vincent Lanteri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Burton Schlecker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

John Sanzone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Michael Esposito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Sergey Rome

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Michael Ciccone

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Eric Margolis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Robert Simon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Yijun Guo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

publication date

2 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

Investigative and clinical urology

1 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

page(s)

423-428

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 4.0 International

1 April 2020

copyright license

start time

1 January 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

mp-MRI Prostate Characterised PIRADS 3 Lesions are Associated with a Low Risk of Clinically Significant Prostate Cancer - A Retrospective Review of 92 Biopsied PIRADS 3 Lesions

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based Screening

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Finding the Wolf in Sheep's Clothing: The 4Kscore Is a Novel Blood Test That Can Accurately Identify the Risk of Aggressive Prostate Cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

The cost implications of prostate cancer screening in the Medicare population.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Screening and prostate-cancer mortality in a randomized European study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Trends in Prostate-specific Antigen Screening, Prostate Biopsies, Urology Visits, and Prostate Cancer Treatments From 2000 to 2012.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5671961

Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Group Practice Following Statement Revision

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29124241

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Pendulum of Prostate Cancer Screening

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29124241

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4111/ICU.2017.58.6.423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124241%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference